Valeant seeks more significant deals in 2014

14 January 2014 - Deborah Wilkes

Archived

Valeant Pharmaceuticals International aims to follow up its US$8.7 billion purchase of global eye health specialist Bausch + Lomb with "at least one significant deal" in 2014.

Click tags below for more information on topics:

Bausch Health

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: